172 related articles for article (PubMed ID: 18435429)
21. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
Manju MA; Candel MJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
[TBL] [Abstract][Full Text] [Related]
22. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency.
Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F
Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233
[TBL] [Abstract][Full Text] [Related]
23. Efficient treatment allocation in two-way nested designs.
Lemme F; van Breukelen GJ; Berger MP
Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
[TBL] [Abstract][Full Text] [Related]
24. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning.
Willan AR; Goeree R; Boutis K
J Clin Epidemiol; 2012 Aug; 65(8):870-6. PubMed ID: 22609138
[TBL] [Abstract][Full Text] [Related]
25. Value of information methods to design a clinical trial in a small population to optimise a health economic utility function.
Pearce M; Hee SW; Madan J; Posch M; Day S; Miller F; Zohar S; Stallard N
BMC Med Res Methodol; 2018 Feb; 18(1):20. PubMed ID: 29422021
[TBL] [Abstract][Full Text] [Related]
26. Health technology assessment, value-based decision making, and innovation.
Henshall C; Schuller T;
Int J Technol Assess Health Care; 2013 Oct; 29(4):353-9. PubMed ID: 23845404
[TBL] [Abstract][Full Text] [Related]
27. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.
Manca A; Sculpher MJ; Goeree R
Pharmacoeconomics; 2010; 28(12):1079-96. PubMed ID: 21080734
[TBL] [Abstract][Full Text] [Related]
28. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
Davies L; Coyle D; Drummond M
Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
[TBL] [Abstract][Full Text] [Related]
29. The value of information and optimal clinical trial design.
Willan AR; Pinto EM
Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
[TBL] [Abstract][Full Text] [Related]
30. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness research in radiology.
Hunink MG
Acad Radiol; 1996 Apr; 3 Suppl 1():S13-6. PubMed ID: 8796498
[No Abstract] [Full Text] [Related]
32. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
[TBL] [Abstract][Full Text] [Related]
33. Clinical decision making and the expected value of information.
Willan AR
Clin Trials; 2007; 4(3):279-85. PubMed ID: 17715257
[TBL] [Abstract][Full Text] [Related]
34. Decision rules and associated sample size planning for regional approval utilizing multiregional clinical trials.
Chen X; Lu N; Nair R; Xu Y; Kang C; Huang Q; Li N; Chen H
J Biopharm Stat; 2012 Sep; 22(5):1001-18. PubMed ID: 22946946
[TBL] [Abstract][Full Text] [Related]
35. Brief report: a cost analysis of neuraxial anesthesia to facilitate external cephalic version for breech fetal presentation.
Carvalho B; Tan JM; Macario A; El-Sayed YY; Sultan P
Anesth Analg; 2013 Jul; 117(1):155-9. PubMed ID: 23592608
[TBL] [Abstract][Full Text] [Related]
36. Expanding Health Technology Assessments to Include Effects on the Environment.
Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
[TBL] [Abstract][Full Text] [Related]
37. Contribution of research networks to a clinical trial of antidepressants in people with dementia.
McCrae N; Douglas L; Banerjee S
J Ment Health; 2012 Oct; 21(5):439-47. PubMed ID: 22548261
[TBL] [Abstract][Full Text] [Related]
38. Managing clustering effects and learning effects in the design and analysis of multicentre randomised trials: a survey to establish current practice.
Conroy EJ; Blazeby JM; Burnside G; Cook JA; Gamble C
Trials; 2020 May; 21(1):433. PubMed ID: 32460815
[TBL] [Abstract][Full Text] [Related]
39. Health technology assessment in the cost-disutility plane.
Eckermann S; Briggs A; Willan AR
Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
[TBL] [Abstract][Full Text] [Related]
40. Regional HTA in Italy: promising or confusing?
Garattini L; van de Vooren K; Curto A
Health Policy; 2012 Dec; 108(2-3):203-6. PubMed ID: 23141760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
